Rainbow Seed Fund News

Perfectus Biomed is delighted to announce the appointment of Dr Lloyd Payne to the role of non-executive director. Perfectus Biomed Group provide accredited standard assays and innovative customised methods for microbiological testing to a wide range of industry sectors including infection prevention, wound care, and medical devices.  Founded by CEO Dr Samantha Westgate in 2012 […]

read more

 Cambridge and Newcastle, UK, 06 January 2021 – Atelerix Ltd (Atelerix) announces the appointment of a new CEO as the company accelerates its growth programme. Over the last four years, the company has been led by co-founder and CEO, Mick McLean, as it developed its products and started commercialisation of its innovative cell encapsulation technology. […]

read more

Coventry, UK, 10th December 2020 / NanoSyrinx announces the appointment of Dr Jane Dancer to its Board as Non-Executive Director. NanoSyrinx is an early-stage biotechnology company using synthetic biology approaches to develop a completely novel platform for targeted drug delivery of therapeutic proteins and peptides, to the interiors of cells. Dr Dancer has over 30 years’ experience […]

read more

1 2 3 4